Media Interviews Online Articles
Adult ADHD Therapy: Finding the Right Therapist
For adults withADHD, the standard treatment is medication. But experts say that ADHD therapy — and other psychosocial treatments — can play a key role alongside drugs. “I think for many adults with ADHD, therapy is essential,” says David W. Goodman MD, assistant professor of psychiatry at the Johns Hopkins University School of Medicine. Recommended Related to ADD-ADHD ADHD Medication […]
Sharing a Diagnosis: When You and Your Child Have ADHD
Your son or daughter was just diagnosed with ADHD, or attention deficit hyperactivity disorder. And as you sat there in the office, listening to the doctor tick off the symptoms – the attention problems, the disorganization, the fidgeting – you recognized yourself. Suddenly, you wonder: Could I have adult ADHD? You very well might. ADHD […]
Celebrity Designer and ADHD Spokesperson Ty Pennington Partners With Shire to Announce the Launch of VYVANSE(TM) (Lisdexamfetamine Dimesylate) for the Treatment of ADHD in Adults
ATLANTA, July 22 /PRNewswire-FirstCall/ — Shire Limited , the global specialty biopharmaceutical company, today announced that it has launched VYVANSE(TM) (lisdexamfetamine dimesylate) for the treatment of adults with Attention Deficit Hyperactivity Disorder (ADHD). This launch follows the recent FDA approval of VYVANSE to treat ADHD in the adult population. VYVANSE is now available in U.S. […]
ADHD Might Raise Kids’ Obesity Risk
MONDAY, July 7 (HealthDay News) — Children with attention-deficit hyperactivity disorder (ADHD) are at a 50 percent higher risk for being overweight if they are not taking medication for the condition, a new study finds. On the other hand, youngsters who were medicated for ADHD had a raised risk of being underweight, the same researchers […]
Adults With ADHD Lose 3 Weeks Worth of Work Annually
TUESDAY, May 27 (HealthDay News) — Adults with attention deficit hyperactivity disorder (ADHD) miss, on average, more than three weeks a year in workplace productivity, according to a new global reckoning of the problem. Altogether, between 3 percent and 4 percent of adults worldwide have ADHD, according to survey data from the World Health Organization […]
FDA Approves Once-Daily Lisdexamfetamine to Treat ADHD in Adults
NEW YORK — April 24, 2008 — The US Food and Drug Administration (FDA) has approved lisdexamfetamine dimesylate (Vyvanse) for the treatment of attention-deficit/hyperactivity disorder (ADHD) in adults. Introduced in July 2007 for the treatment of ADHD in children aged 6 to 12 years, lisdexamfetamine is the first and only once-daily prodrug stimulant approved to […]
A Rational Approach to Diagnosis and Treatment of Attention Deficit/Hyperactivity Disorder (ADHD) in Adolescents and Adults.
Goodman DW. A Rational Approach to Diagnosis and Treatment of Attention Deficit/Hyperactivity Disorder (ADHD) in Adolescents and Adults. Expert Interview. Medscape, June 7, 2007. CME accredited [button size=’large’ color=’btn-b76lpc214h’ link=’https://www.medscape.com/viewarticle/505629′ align=’center’ block=’0′ icon=’FontAwesome/fontawesome-chevron-sign-right||color:ffffff’ shadow=’2′]Read Full Article[/button]
Hyperactive adults need help, too
Like many young mothers, Sophie Currier is a busy woman. There’s all the family stuff at the Brookline home she shares with her partner, Jeremie Gallien , and their 7-month-old son, Theo. There’s work — a teaching assistantship for a biochemistry course at Harvard University. And there’s school. After majoring in biology at the Massachusetts […]
Medicine; Hyperactivity, grown up; ADHD is most often thought of as a childhood disorder, but many adults must learn to cope with its distractions. Prescription drugs and to-do lists can help.
With researchers looking for the genes behind ADHD, it’s also clear that it’s a biological, inherited disorder. It is not, as had been once thought, “caused by bad parenting or weak character,” said Dr. David W. Goodman, a psychiatrist and adult ADHD specialist at Johns Hopkins University School of Medicine, who also consults for companies […]
Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Lisdexamfetamine Dimesylate in Adults With Attention-Deficit/Hyperactivity Disorder.
Lenard A. Adler, M.D.; David W. Goodman, M.D.; Scott H. Kollins, Ph.D.; Richard H. Weisler, M.D.; Suma Krishnan, M.S.; Yuxin Zhang, Ph.D.; and Joseph Biederman, M.D., on behalf of the 303 Study Group. Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Lisdexamfetamine Dimesylate in Adults With Attention-Deficit/Hyperactivity Disorder. Published online ahead of print. J […]